Although cancer cells use myriad arsenal of immunosuppressive mechanisms to escape from the host immune system, PD-L1 (also known as CD274 or B7-H1), seems to be one of the hallmarks of a progressive tumour which can hamper (immuno)therapy efficacy [8]. This evidence concerns the gene CD274 and neoplasm.